Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Seibyl

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Nuclear Medicine and Biology|February 22, 2001
Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primatesSami S Zoghbi, Gilles Tamagnan, Masahiro Fujita, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administrationAkira Kugaya, Nicholas M Seneca, Peter J Snyder, et al.
Bioorganic & Medicinal Chemistry|August 16, 2006
Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PETIdriss Bennacef, Colin N Haile, Anne Schmidt, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 8, 2010
Beta2* nicotinic acetylcholine receptors modulate pain sensitivity in acutely abstinent tobacco smokersKelly P Cosgrove, Irina Esterlis, Sherry McKee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2004
Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPETMasahiro Fujita, Andrea Varrone, Kyeong Min Kim, et al.
The International Journal of Neuropsychopharmacology|January 15, 2008
beta2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorderChristoph Czermak, Julie K Staley, Sue Kasserman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2005
123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibilityJulie K Staley, Christopher H van Dyck, David Weinzimmer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable bindingIrina Esterlis, Kelly P Cosgrove, Jeffery C Batis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairmentEffie M Mitsis, Kristina M Reech, Frederic Bois, et al.
The American Journal of Psychiatry|February 2, 2002
Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorderChristopher H van Dyck, Donald M Quinlan, Lisa M Cretella, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Nuclear Medicine and Biology|February 22, 2001
Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primatesSami S Zoghbi, Gilles Tamagnan, Masahiro Fujita, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administrationAkira Kugaya, Nicholas M Seneca, Peter J Snyder, et al.
Bioorganic & Medicinal Chemistry|August 16, 2006
Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PETIdriss Bennacef, Colin N Haile, Anne Schmidt, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 8, 2010
Beta2* nicotinic acetylcholine receptors modulate pain sensitivity in acutely abstinent tobacco smokersKelly P Cosgrove, Irina Esterlis, Sherry McKee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2004
Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPETMasahiro Fujita, Andrea Varrone, Kyeong Min Kim, et al.
The International Journal of Neuropsychopharmacology|January 15, 2008
beta2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorderChristoph Czermak, Julie K Staley, Sue Kasserman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2005
123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibilityJulie K Staley, Christopher H van Dyck, David Weinzimmer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable bindingIrina Esterlis, Kelly P Cosgrove, Jeffery C Batis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairmentEffie M Mitsis, Kristina M Reech, Frederic Bois, et al.
The American Journal of Psychiatry|February 2, 2002
Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorderChristopher H van Dyck, Donald M Quinlan, Lisa M Cretella, et al.
Pageof 10